17-11929970-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001372.4(DNAH9):āc.11982A>Gā(p.Pro3994=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.304 in 1,613,536 control chromosomes in the GnomAD database, including 77,602 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.26 ( 5576 hom., cov: 31)
Exomes š: 0.31 ( 72026 hom. )
Consequence
DNAH9
NM_001372.4 synonymous
NM_001372.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.51
Genes affected
DNAH9 (HGNC:2953): (dynein axonemal heavy chain 9) This gene encodes the heavy chain subunit of axonemal dynein, a large multi-subunit molecular motor. Axonemal dynein attaches to microtubules and hydrolyzes ATP to mediate the movement of cilia and flagella. The gene expresses at least two transcript variants; additional variants have been described, but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 17-11929970-A-G is Benign according to our data. Variant chr17-11929970-A-G is described in ClinVar as [Benign]. Clinvar id is 402784.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.51 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.327 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH9 | NM_001372.4 | c.11982A>G | p.Pro3994= | synonymous_variant | 63/69 | ENST00000262442.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH9 | ENST00000262442.9 | c.11982A>G | p.Pro3994= | synonymous_variant | 63/69 | 1 | NM_001372.4 | P1 | |
DNAH9 | ENST00000608377.5 | c.918A>G | p.Pro306= | synonymous_variant | 9/15 | 1 | |||
DNAH9 | ENST00000396001.6 | n.1445A>G | non_coding_transcript_exon_variant | 9/15 | 1 | ||||
DNAH9 | ENST00000454412.6 | c.11878-2044A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.256 AC: 38808AN: 151868Hom.: 5574 Cov.: 31
GnomAD3 genomes
AF:
AC:
38808
AN:
151868
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.285 AC: 71526AN: 250620Hom.: 10949 AF XY: 0.294 AC XY: 39843AN XY: 135452
GnomAD3 exomes
AF:
AC:
71526
AN:
250620
Hom.:
AF XY:
AC XY:
39843
AN XY:
135452
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.310 AC: 452413AN: 1461548Hom.: 72026 Cov.: 37 AF XY: 0.312 AC XY: 226953AN XY: 727034
GnomAD4 exome
AF:
AC:
452413
AN:
1461548
Hom.:
Cov.:
37
AF XY:
AC XY:
226953
AN XY:
727034
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.255 AC: 38810AN: 151988Hom.: 5576 Cov.: 31 AF XY: 0.256 AC XY: 19004AN XY: 74278
GnomAD4 genome
AF:
AC:
38810
AN:
151988
Hom.:
Cov.:
31
AF XY:
AC XY:
19004
AN XY:
74278
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
826
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at